Lacassagne Emmanuelle, Dhuez Aurore, Rigaudière Florence, Dansault Anouk, Vêtu Christelle, Bigot Karine, Vieira Véronique, Puech Bernard, Defoort-Dhellemmes Sabine, Abitbol Marc
Université Paris-Descartes, Faculté de Médecine Paris Descartes-site Necker, CERTO, Paris, France.
Mol Vis. 2011 Jan 29;17:309-22.
To describe genetic and clinical findings in a French family affected by best vitelliform macular dystrophy (BVMD).
We screened eight at-risk members of a family, including a BVMD-affected proband, by direct sequencing of 11 bestrophin-1 (BEST1) exons. Individuals underwent ophthalmic examination and autofluorescent fundus imaging, indocyanine green angiography, electro-oculogram (EOG), electroretinogram (ERG), multifocal ERG, optical coherence tomography (OCT), and where possible, spectral domain OCT.
The sequence analysis of the BEST1 gene revealed one previously unknown mutation, c.15C>A (p.Y5X), in two family members and one recently described mutation, c.430A>G (p.S144G), in five family members. Fundus examination and electrophysiological responses provided no evidence of the disease in the patient carrying only the p.Y5X mutation. Three patients with the p.S144G mutation did not show any preclinical sign of BVMD except altered EOGs. Two individuals of the family exhibited a particularly severe phenotype of multifocal BVMD-one individual carrying the p.S144G mutation heterozygously and one individual harboring both BEST1 mutations (p.S144G inherited from his mother and p.Y5X from his father). Both of these family members had multifocal vitelliform autofluorescent lesions combined with abnormal EOG, and the spectral domain OCT displayed a serous retinal detachment. In addition, ERGs demonstrated widespread retinal degeneration and multifocal ERGs showed a reduction in the central retina function, which could be correlated with the decreased visual acuity and visual field scotomas.
A thorough clinical evaluation found no pathological phenotype in the patient carrying the isolated p.Y5X mutation. The patients carrying the p.S144G variation in the protein exhibited considerable intrafamilial phenotypic variability. Two young affected patients in this family exhibited an early onset, severe, multifocal BVMD with a diffuse distribution of autofluorescent deposits throughout the retina and rapid evolution toward the loss of central vision. The other genetically affected relatives had only abnormal EOGs and displayed no or extremely slow electrophysiological evolution.
描述一个受最佳卵黄样黄斑营养不良(BVMD)影响的法国家庭的遗传学和临床特征。
我们通过对11个贝斯特罗芬蛋白-1(BEST1)外显子进行直接测序,对一个家庭的8名高危成员进行了筛查,其中包括一名受BVMD影响的先证者。所有个体均接受了眼科检查、自发荧光眼底成像、吲哚菁绿血管造影、眼电图(EOG)、视网膜电图(ERG)、多焦ERG、光学相干断层扫描(OCT),并在可能的情况下进行了光谱域OCT检查。
BEST1基因的序列分析显示,两名家庭成员存在一个先前未知的突变c.15C>A(p.Y5X),五名家庭成员存在一个最近报道的突变c.430A>G(p.S144G)。眼底检查和电生理反应表明,仅携带p.Y5X突变的患者未出现该疾病的迹象。三名携带p.S144G突变的患者除了EOG改变外,未表现出任何BVMD的临床前期迹象。该家庭中有两名个体表现出一种特别严重的多灶性BVMD表型,一名个体为p.S144G突变杂合子,另一名个体同时携带两种BEST1突变(从母亲遗传的p.S144G和从父亲遗传的p.Y5X)。这两名家庭成员均有多灶性卵黄样自发荧光病变,并伴有异常EOG,光谱域OCT显示浆液性视网膜脱离。此外,ERG显示广泛的视网膜变性,多焦ERG显示中心视网膜功能下降,这与视力下降和视野暗点相关。
全面的临床评估发现,携带孤立p.Y5X突变的患者未出现病理表型。携带p.S144G蛋白变异的患者在家族内表现出显著的表型变异性。该家庭中的两名年轻患病患者表现为早发性、严重的多灶性BVMD,自发荧光沉积物在整个视网膜弥漫分布,并迅速发展为中心视力丧失。其他遗传上受影响的亲属仅EOG异常,未表现出或仅有极其缓慢的电生理进展。